Dragonfly Security Corp is a clinical-stage biotech company based in Waltham, MA, specializing in inventing novel therapies that harness the body's immune system to fight diseases. With a deep portfolio of drugs built on two unique platforms, TriNKET and CYTOKINE, Dragonfly has developed a range of drug candidates in collaboration with renowned pharmaceutical partners. Their pipeline is rapidly growing, addressing critical patient needs in various therapeutic areas, including oncology, immunology, neuromuscular disease, virology, and more.
Dragonfly's innovative approach and successful clinical trials have positioned them as a distinctively effective pharma partner, rapidly developing drugs with their collaborators. With a commitment to improving patient outcomes, Dragonfly is dedicated to activating the immune system to combat diseases, offering hope and potential breakthroughs in the field of healthcare.
Generated from the website